HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew B Renfrow Selected Research

Autoantibodies

1/2018Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
11/2016Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy.
5/2015New Insights into the Pathogenesis of IgA Nephropathy.
11/2013Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew B Renfrow Research Topics

Disease

22IGA Glomerulonephritis (IGA Nephropathy)
11/2023 - 05/2005
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 05/2012
3Glomerulonephritis
11/2023 - 01/2016
3Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 05/2015
2Neoplasms (Cancer)
11/2022 - 01/2019
2IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2021 - 01/2007
2Nephritis
01/2021 - 01/2007
2Infections
07/2015 - 08/2009
2Immune Complex Diseases (Immune Complex Disease)
05/2013 - 05/2012
2Disease Progression
05/2013 - 05/2012
1Renal Insufficiency (Renal Failure)
11/2023
1Thrombosis (Thrombus)
01/2019
1Inflammation (Inflammations)
01/2019
1Carcinogenesis
07/2015
1Proteinuria
05/2015
1Poisoning
02/2014
1Tuberculosis (Tuberculoses)
02/2014
1Parkinson Disease (Parkinson's Disease)
09/2011
1Multiple Myeloma
04/2010
1Fibrosis (Cirrhosis)
02/2008
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2008
1Alzheimer Disease (Alzheimer's Disease)
09/2007

Drug/Important Bio-Agent (IBA)

20Immunoglobulin A (IgA)IBA
11/2022 - 05/2005
10Polysaccharides (Glycans)IBA
01/2019 - 05/2005
8Galactose (Galactopyranose)FDA LinkGeneric
11/2022 - 01/2007
8Antigen-Antibody Complex (Immune Complex)IBA
08/2021 - 05/2005
5Immunoglobulin G (IgG)IBA
01/2018 - 05/2012
5galactosyl-deficient IgA1IBA
01/2018 - 11/2013
4AutoantigensIBA
01/2019 - 02/2015
4AutoantibodiesIBA
01/2018 - 11/2013
4Biomarkers (Surrogate Marker)IBA
05/2015 - 05/2012
3Immunoglobulins (Immunoglobulin)IBA
11/2023 - 10/2013
2Complement System Proteins (Complement)IBA
11/2023 - 11/2013
2Proteins (Proteins, Gene)FDA Link
10/2013 - 09/2007
1Triglycerides (Triacylglycerol)IBA
11/2022
1AntibodiesIBA
01/2019
1Sulfhydryl Compounds (Thiols)IBA
01/2019
1human neutrophil peptide 1IBA
01/2019
1Therapeutic UsesIBA
01/2019
1Cysteine (L-Cysteine)FDA Link
01/2019
1Complementarity Determining Regions (Complementarity Determining Region)IBA
11/2016
1VaccinesIBA
07/2015
1VLDL LipoproteinsIBA
07/2015
1Antiviral Agents (Antivirals)IBA
07/2015
1Angiotensin IIIBA
05/2015
1EnzymesIBA
02/2015
1SiderophoresIBA
02/2014
1mycobactinsIBA
02/2014
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2014
1AcetylgalactosamineIBA
01/2014
1Complement Factor H (Factor H)IBA
11/2013
1GuanosineIBA
09/2011
1Myelin Basic ProteinIBA
09/2011
1Leucine (L-Leucine)FDA Link
09/2011
1Phosphotransferases (Kinase)IBA
09/2011
1Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA
09/2011
1GTP Phosphohydrolases (GTPases)IBA
09/2011
1Reducing AgentsIBA
08/2009
1Fatty Acids (Saturated Fatty Acids)IBA
08/2009
1LipidsIBA
08/2009
1Atrial Natriuretic Factor (ANF)IBA
02/2008
1CollagenIBA
02/2008
1Myeloma ProteinsIBA
11/2007
1AldehydesIBA
09/2007
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
09/2007
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2007

Therapy/Procedure

4Therapeutics
01/2019 - 10/2011
1Chemoprevention
11/2022
1Cyclotrons
11/2007